Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Purdue Pharma: Abuse rates of OxyContin significantly down three years after reformulation
Drug Store News
Monday, September 8, 2014 - 12:26pm
tags:
Purdue Pharma, painkillers, oxycontin, oxycodone, drug abuse
District Court Orders FDA to Recognize Orphan Drug Exclusivity for GRALISE
FDA Law Blog
Monday, September 8, 2014 - 12:22pm
tags:
FDA, orphan drugs, Depomed, Gralise
The FDA Has Approved How Many Novel New Drugs So Far This Year?
WSJ Pharmalot
Monday, September 8, 2014 - 12:21pm
tags:
drug approvals, FDA
Sales layoffs may be ahead as Hospira loses fight against Precedex generics
Fierce Pharma
Monday, September 8, 2014 - 12:17pm
tags:
Hospira, layoffs, Precedex, generics
Counterclaims stand in whistleblower lawsuit against Boston Scientific
Mass Device
Monday, September 8, 2014 - 12:16pm
tags:
Boston Scientific, whistleblower lawsuits, devices, Medicare, Medicaid
Biotech Company Hemispherx Goes Nuts After Announcing Collaboration With US On Ebola Treatment
Yahoo/Business Insider
Monday, September 8, 2014 - 9:56am
tags:
Hemispherx Biopharma, ebola virus, government contracts
Hyperion stops diabetes drug development
Yahoo/Reuters
Monday, September 8, 2014 - 9:54am
tags:
Hyperion Therapeutics, diabetes
Jazz looks more attractive for Allergan than Salix, says Wells Fargo
The Fly on the Wall
Monday, September 8, 2014 - 9:35am
tags:
Jazz Pharmaceuticals, Allergan, Salix, M&A
Novartis Wins The Battle Over Bronchodilators Against GSK
Bidness Etc.
Monday, September 8, 2014 - 8:28am
tags:
Novartis, GSK, bronchodilator, Ultibro Breezhaler, Seretide, asthma
French company Carmat fits second patient with artificial heart
Yahoo/Reuters
Monday, September 8, 2014 - 8:21am
tags:
Carmat, Artificial Heart, devices
Astellas files new drug for life-threatening infections
Pharmaphorum
Monday, September 8, 2014 - 8:19am
tags:
Astellas, isavuconazole, antifungals
Legal Battles Over Labeling Continue Between Generic And Brand-Name Manufacturers
Bidness Etc.
Monday, September 8, 2014 - 8:01am
tags:
generics, Merck, Fosamax
Why Is Novartis Investing in This $49 Billion Market?
Motley Fool
Monday, September 8, 2014 - 7:58am
tags:
Novartis, mobile apps
Report: Google's Calico going on hiring spree after AbbVie tie-up
Fierce Biotech
Monday, September 8, 2014 - 7:56am
tags:
AbbVie, Google, Calico, hirings
AstraZeneca's self-styled 'blockbuster' benralizumab tanks in severe COPD study
Fierce Biotech
Monday, September 8, 2014 - 7:55am
tags:
AstraZeneca, benralizumab, COPD
Why Valeant's Hostile Takeover Bid of Allergan Is Bad for Shareholders
TheStreet.com
Monday, September 8, 2014 - 7:50am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label
TheStreet.com
Monday, September 8, 2014 - 7:49am
tags:
Keryx, Zerenex
Is there a cure for pharma’s innovation problem?
CNBC
Monday, September 8, 2014 - 7:48am
tags:
innovation
Leading Anti-Marijuana Academics Are Paid By Painkiller Drug Companies
Vice
Sunday, September 7, 2014 - 11:26am
tags:
marijuana, Medical Marijuana, pain management
Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC
Yahoo/PR Newswire
Sunday, September 7, 2014 - 10:48am
tags:
Synthetic Biologics, C. difficile, P3A, P4A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.